Knowledge, attitude and practice scores in the general population and according to regions. by Sara Saleh (6733619)

Subjects:

The raw data file. by Sara Saleh (6733619)

Subjects:

Side effects of vaccination that affected participants’ children. by Sara Saleh (6733619)

Subjects:

Status (A) and duration (B) of breast feeding among participants. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the knowledge scores. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the attitude scores. by Sara Saleh (6733619)

Subjects:

Multivariate analysis of sociodemographic and other factors associated with the KAP scores. by Sara Saleh (6733619)

Subjects:

Participants’ perceived ways to boost children’s immune system other than vaccination. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the practice scores. by Sara Saleh (6733619)

Subjects:

Association between CAP value and carotid-femoral pulse wave velocity. by Johannes Nairz (18010746)

Subjects:

Characteristics of the study population. by Johannes Nairz (18010746)

Subjects:

Boxplot mean cfPWV comparisons. by Johannes Nairz (18010746)

Subjects:

Study flow chart. by Johannes Nairz (18010746)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects: